Sample
|
PDE-5 (μg/mL)
|
Arginase (μg/mL)
|
ACE (μg/mL)
|
AChE (μg/mL)
|
FRAP (μg/mL)
|
DPPH (μg/mL)
|
---|
Penis
|
43.19 ± 0.02c
|
46.12 ± 0.15c
|
44.23 ± 0.71a
|
55.51 ± 0.45a
|
–
|
–
|
Testes
|
44.67 ± 0.01b
|
49.12 ± 0.12b
|
53.99 ± 0.85a
|
60.03 ± 0.34a
|
–
|
–
|
Sildenafil (μg/mL)
|
26.65 ± 0.10a
|
–
|
–
|
–
|
–
|
–
|
L-NOHA (μg/mL)
|
–
|
42.48 ± 0.21a
|
–
|
–
|
–
|
–
|
Lisinopril (μg/mL)
|
–
|
–
|
38.34 ± 0.01a
|
–
|
–
|
–
|
Prostigmine (μg/mL)
|
–
|
–
|
–
|
48.01 ± 1.02a
|
–
|
–
|
Vitamin C (μg/mL)
|
–
|
–
|
–
|
–
|
46.16 ± 0.51a
|
53.81 ± 0.02a
|
O. gratissimum extract
|
–
|
–
|
–
|
–
|
56.55 ± 0.78a
|
69.41 ± 0.01a
|
- Values represent mean ± standard deviation (n = 3). Values with the same superscript along the column are not significant (p < 0.05) different. Sildenafil*: standard drug for phosphodiesterase-5 (PDE-5); L-NOHA*: standard inhibitor for arginase; prostigmine*: standard drugs for AChE; Lisinopril*: standard drug for ACE; Vitamin C*: standard drug for ferric reducing power (FRAP) and DPPH